APO Research

APO RESEARCH · REPORT

Cosmetic Efficacy Testing

Selected research

Market Analysis & Forecast

Global Cosmetic Efficacy Testing Market Analysis and Forecast 2026-2032

Market perspective

The global Cosmetic Efficacy Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cosmetic Efficacy Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cosmetic Efficacy Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cosmetic Efficacy Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cosmetic Efficacy Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cosmetic Efficacy Testing include SGS, Eurofins, Measurlabs, QACS labs, Chemleg, Evalulab, QIMA Life Sciences, Intertek and Biorius, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cosmetic Efficacy Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cosmetic Efficacy Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Cosmetic Efficacy Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cosmetic Efficacy Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cosmetic Efficacy Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cosmetic Efficacy Testing revenue, projected growth trends, production technology, application and end-user industry.

Cosmetic Efficacy Testing Segment by Company

SGS

Eurofins

Measurlabs

QACS labs

Chemleg

Evalulab

QIMA Life Sciences

Intertek

Biorius

Oxford Biosciences

FDA

CTI

Luamed

Cosmeservice

CPT Labs

Microchem Laboratory

XCellR9

Future Cosmetics

Complife Group

Melbec Microbiology

Kirei Testing

Accugen Labs

MSL Solution

BluTest

Creative Bioarray

Iwase Cosfa

Dermaclaim Lab

Labskin

PCR

TIBD

Alliance Analytical Laboratories

Abich

HAPPI

Cosmetri

MCS

Spincontrol

Cosmetic Efficacy Testing Segment by Type

In Vitro Testing

In Vivo Testing

Cosmetic Efficacy Testing Segment by Application

Skincare Products

Haircare Products

Makeup Products

Oral Care Products

Other

Cosmetic Efficacy Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cosmetic Efficacy Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cosmetic Efficacy Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cosmetic Efficacy Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cosmetic Efficacy Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cosmetic Efficacy Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cosmetic Efficacy Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cosmetic Efficacy Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. In Vitro Testing Major Player Table 3. In Vivo Testing Major Player Table 4. Global Cosmetic Efficacy Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Skincare Products Major Player Table 6. Haircare Products Major Player Table 7. Makeup Products Major Player Table 8. Oral Care Products Major Player Table 9. Other Major Player Table 10. Cosmetic Efficacy Testing Industry Trends Table 11. Cosmetic Efficacy Testing Industry Drivers Table 12. Cosmetic Efficacy Testing Industry Opportunities and Challenges Table 13. Cosmetic Efficacy Testing Industry Restraints Table 14. Global Cosmetic Efficacy Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Cosmetic Efficacy Testing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Cosmetic Efficacy Testing Market Share by Region (2021-2026) Table 17. Global Cosmetic Efficacy Testing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Cosmetic Efficacy Testing Market Share by Region (2027-2032) Table 19. Global Cosmetic Efficacy Testing Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Cosmetic Efficacy Testing Revenue Market Share by Players (2021-2026) Table 21. Global Cosmetic Efficacy Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Cosmetic Efficacy Testing Key Players Headquarters & Area Served Table 23. Global Cosmetic Efficacy Testing Players, Product Type & Application Table 24. Global Cosmetic Efficacy Testing Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Cosmetic Efficacy Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Cosmetic Efficacy Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Cosmetic Efficacy Testing Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Cosmetic Efficacy Testing Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Cosmetic Efficacy Testing Revenue Market Share by Type (2021-2026) Table 31. Global Cosmetic Efficacy Testing Revenue Market Share by Type (2027-2032) Table 32. Global Cosmetic Efficacy Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Cosmetic Efficacy Testing Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Cosmetic Efficacy Testing Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Cosmetic Efficacy Testing Revenue Market Share by Application (2021-2026) Table 36. Global Cosmetic Efficacy Testing Revenue Market Share by Application (2027-2032) Table 37. SGS Company Information Table 38. SGS Business Overview Table 39. SGS Cosmetic Efficacy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. SGS Cosmetic Efficacy Testing Product Portfolio Table 41. SGS Recent Development Table 42. Eurofins Company Information Table 43. Eurofins Business Overview Table 44. Eurofins Cosmetic Efficacy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Eurofins Cosmetic Efficacy Testing Product Portfolio Table 46. Eurofins Recent Development Table 47. Measurlabs Company Information Table 48. Measurlabs Business Overview Table 49. Measurlabs Cosmetic Efficacy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Measurlabs Cosmetic Efficacy Testing Product Portfolio Table 51. Measurlabs Recent Development Table 52. QACS labs Company Information Table 53. QACS labs Business Overview Table 54. QACS labs Cosmetic Efficacy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. QACS labs Cosmetic Efficacy Testing Product Portfolio Table 56. QACS labs Recent Development Table 57. Chemleg Company Information Table 58. Chemleg Business Overview Table 59. Chemleg Cosmetic Efficacy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Chemleg Cosmetic Efficacy Testing Product Portfolio Table 61. Chemleg Recent Development Table 62. Evalulab Company Information Table 63. Evalulab Business Overview Table 64. Evalulab Cosmetic Efficacy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Evalulab Cosmetic Efficacy Testing Product Portfolio Table 66. Evalulab Recent Development Table 67. QIMA Life Sciences Company Information Table 68. QIMA Life Sciences Business Overview Table 69. QIMA Life Sciences Cosmetic Efficacy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. QIMA Life Sciences Cosmetic Efficacy Testing Product Portfolio Table 71. QIMA Life Sciences Recent Development Table 72. Intertek Company Information Table 73. Intertek Business Overview Table 74. Intertek Cosmetic Efficacy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Intertek Cosmetic Efficacy Testing Product Portfolio Table 76. Intertek Recent Development Table 77. Biorius Company Information Table 78. Biorius Business Overview Table 79. Biorius Cosmetic Efficacy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Biorius Cosmetic Efficacy Testing Product Portfolio Table 81. Biorius Recent Development Table 82. Oxford Biosciences Company Information Table 83. Oxford Biosciences Business Overview Table 84. Oxford Biosciences Cosmetic Efficacy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Oxford Biosciences Cosmetic Efficacy Testing Product Portfolio Table 86. Oxford Biosciences Recent Development Table 87. FDA Company Information Table 88. FDA Business Overview Table 89. FDA Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. FDA Cosmetic Efficacy Testing Product Portfolio Table 91. FDA Recent Development Table 92. CTI Company Information Table 93. CTI Business Overview Table 94. CTI Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. CTI Cosmetic Efficacy Testing Product Portfolio Table 96. CTI Recent Development Table 97. Luamed Company Information Table 98. Luamed Business Overview Table 99. Luamed Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Luamed Cosmetic Efficacy Testing Product Portfolio Table 101. Luamed Recent Development Table 102. Cosmeservice Company Information Table 103. Cosmeservice Business Overview Table 104. Cosmeservice Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Cosmeservice Cosmetic Efficacy Testing Product Portfolio Table 106. Cosmeservice Recent Development Table 107. CPT Labs Company Information Table 108. CPT Labs Business Overview Table 109. CPT Labs Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. CPT Labs Cosmetic Efficacy Testing Product Portfolio Table 111. CPT Labs Recent Development Table 112. Microchem Laboratory Company Information Table 113. Microchem Laboratory Business Overview Table 114. Microchem Laboratory Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Microchem Laboratory Cosmetic Efficacy Testing Product Portfolio Table 116. Microchem Laboratory Recent Development Table 117. XCellR9 Company Information Table 118. XCellR9 Business Overview Table 119. XCellR9 Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. XCellR9 Cosmetic Efficacy Testing Product Portfolio Table 121. XCellR9 Recent Development Table 122. Future Cosmetics Company Information Table 123. Future Cosmetics Business Overview Table 124. Future Cosmetics Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Future Cosmetics Cosmetic Efficacy Testing Product Portfolio Table 126. Future Cosmetics Recent Development Table 127. Complife Group Company Information Table 128. Complife Group Business Overview Table 129. Complife Group Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Complife Group Cosmetic Efficacy Testing Product Portfolio Table 131. Complife Group Recent Development Table 132. Melbec Microbiology Company Information Table 133. Melbec Microbiology Business Overview Table 134. Melbec Microbiology Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Melbec Microbiology Cosmetic Efficacy Testing Product Portfolio Table 136. Melbec Microbiology Recent Development Table 137. Kirei Testing Company Information Table 138. Kirei Testing Business Overview Table 139. Kirei Testing Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Kirei Testing Cosmetic Efficacy Testing Product Portfolio Table 141. Kirei Testing Recent Development Table 142. Accugen Labs Company Information Table 143. Accugen Labs Business Overview Table 144. Accugen Labs Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Accugen Labs Cosmetic Efficacy Testing Product Portfolio Table 146. Accugen Labs Recent Development Table 147. MSL Solution Company Information Table 148. MSL Solution Business Overview Table 149. MSL Solution Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. MSL Solution Cosmetic Efficacy Testing Product Portfolio Table 151. MSL Solution Recent Development Table 152. BluTest Company Information Table 153. BluTest Business Overview Table 154. BluTest Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. BluTest Cosmetic Efficacy Testing Product Portfolio Table 156. BluTest Recent Development Table 157. Creative Bioarray Company Information Table 158. Creative Bioarray Business Overview Table 159. Creative Bioarray Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Creative Bioarray Cosmetic Efficacy Testing Product Portfolio Table 161. Creative Bioarray Recent Development Table 162. Iwase Cosfa Company Information Table 163. Iwase Cosfa Business Overview Table 164. Iwase Cosfa Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Iwase Cosfa Cosmetic Efficacy Testing Product Portfolio Table 166. Iwase Cosfa Recent Development Table 167. Dermaclaim Lab Company Information Table 168. Dermaclaim Lab Business Overview Table 169. Dermaclaim Lab Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Dermaclaim Lab Cosmetic Efficacy Testing Product Portfolio Table 171. Dermaclaim Lab Recent Development Table 172. Labskin Company Information Table 173. Labskin Business Overview Table 174. Labskin Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Labskin Cosmetic Efficacy Testing Product Portfolio Table 176. Labskin Recent Development Table 177. PCR Company Information Table 178. PCR Business Overview Table 179. PCR Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. PCR Cosmetic Efficacy Testing Product Portfolio Table 181. PCR Recent Development Table 182. TIBD Company Information Table 183. TIBD Business Overview Table 184. TIBD Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. TIBD Cosmetic Efficacy Testing Product Portfolio Table 186. TIBD Recent Development Table 187. Alliance Analytical Laboratories Company Information Table 188. Alliance Analytical Laboratories Business Overview Table 189. Alliance Analytical Laboratories Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. Alliance Analytical Laboratories Cosmetic Efficacy Testing Product Portfolio Table 191. Alliance Analytical Laboratories Recent Development Table 192. Abich Company Information Table 193. Abich Business Overview Table 194. Abich Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 195. Abich Cosmetic Efficacy Testing Product Portfolio Table 196. Abich Recent Development Table 197. HAPPI Company Information Table 198. HAPPI Business Overview Table 199. HAPPI Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 200. HAPPI Cosmetic Efficacy Testing Product Portfolio Table 201. HAPPI Recent Development Table 202. Cosmetri Company Information Table 203. Cosmetri Business Overview Table 204. Cosmetri Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 205. Cosmetri Cosmetic Efficacy Testing Product Portfolio Table 206. Cosmetri Recent Development Table 207. MCS Company Information Table 208. MCS Business Overview Table 209. MCS Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 210. MCS Cosmetic Efficacy Testing Product Portfolio Table 211. MCS Recent Development Table 212. Spincontrol Company Information Table 213. Spincontrol Business Overview Table 214. Spincontrol Cosmetic Efficacy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 215. Spincontrol Cosmetic Efficacy Testing Product Portfolio Table 216. Spincontrol Recent Development Table 217. North America Cosmetic Efficacy Testing Revenue by Type (2021-2026) & (US$ Million) Table 218. North America Cosmetic Efficacy Testing Revenue by Type (2027-2032) & (US$ Million) Table 219. North America Cosmetic Efficacy Testing Revenue by Application (2021-2026) & (US$ Million) Table 220. North America Cosmetic Efficacy Testing Revenue by Application (2027-2032) & (US$ Million) Table 221. North America Cosmetic Efficacy Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. North America Cosmetic Efficacy Testing Revenue by Country (2021-2026) & (US$ Million) Table 223. North America Cosmetic Efficacy Testing Revenue by Country (US$ Million) & (2027-2032) Table 224. Europe Cosmetic Efficacy Testing Revenue by Type (2021-2026) & (US$ Million) Table 225. Europe Cosmetic Efficacy Testing Revenue by Type (2027-2032) & (US$ Million) Table 226. Europe Cosmetic Efficacy Testing Revenue by Application (2021-2026) & (US$ Million) Table 227. Europe Cosmetic Efficacy Testing Revenue by Application (2027-2032) & (US$ Million) Table 228. Europe Cosmetic Efficacy Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. Europe Cosmetic Efficacy Testing Revenue by Country (2021-2026) & (US$ Million) Table 230. Europe Cosmetic Efficacy Testing Revenue by Country (US$ Million) & (2027-2032) Table 231. China Cosmetic Efficacy Testing Revenue by Type (2021-2026) & (US$ Million) Table 232. China Cosmetic Efficacy Testing Revenue by Type (2027-2032) & (US$ Million) Table 233. China Cosmetic Efficacy Testing Revenue by Application (2021-2026) & (US$ Million) Table 234. China Cosmetic Efficacy Testing Revenue by Application (2027-2032) & (US$ Million) Table 235. Asia Cosmetic Efficacy Testing Revenue by Type (2021-2026) & (US$ Million) Table 236. Asia Cosmetic Efficacy Testing Revenue by Type (2027-2032) & (US$ Million) Table 237. Asia Cosmetic Efficacy Testing Revenue by Application (2021-2026) & (US$ Million) Table 238. Asia Cosmetic Efficacy Testing Revenue by Application (2027-2032) & (US$ Million) Table 239. Asia Cosmetic Efficacy Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 240. Asia Cosmetic Efficacy Testing Revenue by Region (US$ Million) & (2021-2026) Table 241. Asia Cosmetic Efficacy Testing Revenue by Region (US$ Million) & (2027-2032) Table 242. SAMEA Cosmetic Efficacy Testing Revenue by Type (2021-2026) & (US$ Million) Table 243. SAMEA Cosmetic Efficacy Testing Revenue by Type (2027-2032) & (US$ Million) Table 244. SAMEA Cosmetic Efficacy Testing Revenue by Application (2021-2026) & (US$ Million) Table 245. SAMEA Cosmetic Efficacy Testing Revenue by Application (2027-2032) & (US$ Million) Table 246. SAMEA Cosmetic Efficacy Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. SAMEA Cosmetic Efficacy Testing Revenue by Country (2021-2026) & (US$ Million) Table 248. SAMEA Cosmetic Efficacy Testing Revenue by Country (US$ Million) & (2027-2032) Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Cosmetic Efficacy Testing Image Figure 2. Global Cosmetic Efficacy Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cosmetic Efficacy Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. In Vitro Testing Image Figure 5. In Vivo Testing Image Figure 6. Global Cosmetic Efficacy Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cosmetic Efficacy Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Skincare Products Image Figure 9. Haircare Products Image Figure 10. Makeup Products Image Figure 11. Oral Care Products Image Figure 12. Other Image Figure 13. Global Cosmetic Efficacy Testing Market Size (US$ Million) & (2021-2032) Figure 14. Global Cosmetic Efficacy Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Cosmetic Efficacy Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Cosmetic Efficacy Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Cosmetic Efficacy Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cosmetic Efficacy Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Cosmetic Efficacy Testing Revenue Market Share by Type (2021-2032) Figure 21. Global Cosmetic Efficacy Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Cosmetic Efficacy Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Cosmetic Efficacy Testing Revenue Market Share by Application (2021-2032) Figure 24. North America Cosmetic Efficacy Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Cosmetic Efficacy Testing Revenue Share by Type (2021-2032) Figure 26. North America Cosmetic Efficacy Testing Revenue Share by Application (2021-2032) Figure 27. North America Cosmetic Efficacy Testing Revenue Share by Country (2021-2032) Figure 28. United States Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Cosmetic Efficacy Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Cosmetic Efficacy Testing Revenue Share by Type (2021-2032) Figure 33. Europe Cosmetic Efficacy Testing Revenue Share by Application (2021-2032) Figure 34. Europe Cosmetic Efficacy Testing Revenue Share by Country (2021-2032) Figure 35. Germany Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Cosmetic Efficacy Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Cosmetic Efficacy Testing Revenue Share by Type (2021-2032) Figure 45. China Cosmetic Efficacy Testing Revenue Share by Application (2021-2032) Figure 46. Asia Cosmetic Efficacy Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Cosmetic Efficacy Testing Revenue Share by Type (2021-2032) Figure 48. Asia Cosmetic Efficacy Testing Revenue Share by Application (2021-2032) Figure 49. Asia Cosmetic Efficacy Testing Revenue Share by Region (2021-2032) Figure 50. Japan Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Cosmetic Efficacy Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Cosmetic Efficacy Testing Revenue Share by Type (2021-2032) Figure 58. SAMEA Cosmetic Efficacy Testing Revenue Share by Application (2021-2032) Figure 59. SAMEA Cosmetic Efficacy Testing Revenue Share by Country (2021-2032) Figure 60. Brazil Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Cosmetic Efficacy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro Testing
  • In Vivo Testing
Applications
  • Skincare Products
  • Haircare Products
  • Makeup Products
  • Oral Care Products
  • Other
Companies covered
  • SGS
  • Eurofins
  • Measurlabs
  • QACS labs
  • Chemleg
  • Evalulab
  • QIMA Life Sciences
  • Intertek
  • Biorius
  • Oxford Biosciences
  • FDA
  • CTI
  • Luamed
  • Cosmeservice
  • CPT Labs
  • Microchem Laboratory
  • XCellR9
  • Future Cosmetics
  • Complife Group
  • Melbec Microbiology
  • Kirei Testing
  • Accugen Labs
  • MSL Solution
  • BluTest
  • Creative Bioarray
  • Iwase Cosfa
  • Dermaclaim Lab
  • Labskin
  • PCR
  • TIBD
  • Alliance Analytical Laboratories
  • Abich
  • HAPPI
  • Cosmetri
  • MCS
  • Spincontrol

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cosmetic Efficacy Testing Market by Type
  3. 1.2.1 Global Cosmetic Efficacy Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 In Vitro Testing
  5. 1.2.3 In Vivo Testing
  6. 1.3 Cosmetic Efficacy Testing Market by Application
  7. 1.3.1 Global Cosmetic Efficacy Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Skincare Products
  9. 1.3.3 Haircare Products
  10. 1.3.4 Makeup Products
  11. 1.3.5 Oral Care Products
  12. 1.3.6 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Cosmetic Efficacy Testing Market Dynamics
  1. 2.1 Cosmetic Efficacy Testing Industry Trends
  2. 2.2 Cosmetic Efficacy Testing Industry Drivers
  3. 2.3 Cosmetic Efficacy Testing Industry Opportunities and Challenges
  4. 2.4 Cosmetic Efficacy Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cosmetic Efficacy Testing Market Perspective (2021-2032)
  2. 3.2 Global Cosmetic Efficacy Testing Growth Trends by Region
  3. 3.2.1 Global Cosmetic Efficacy Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cosmetic Efficacy Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Cosmetic Efficacy Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cosmetic Efficacy Testing Revenue by Players
  2. 4.1.1 Global Cosmetic Efficacy Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Cosmetic Efficacy Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cosmetic Efficacy Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cosmetic Efficacy Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cosmetic Efficacy Testing Key Players Headquarters & Area Served
  7. 4.4 Global Cosmetic Efficacy Testing Players, Product Type & Application
  8. 4.5 Global Cosmetic Efficacy Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cosmetic Efficacy Testing Market CR5 and HHI
  11. 4.6.3 2025 Cosmetic Efficacy Testing Tier 1, Tier 2, and Tier 3
5 Cosmetic Efficacy Testing Market Size by Type
  1. 5.1 Global Cosmetic Efficacy Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cosmetic Efficacy Testing Revenue by Type (2021-2032)
  3. 5.3 Global Cosmetic Efficacy Testing Revenue Market Share by Type (2021-2032)
6 Cosmetic Efficacy Testing Market Size by Application
  1. 6.1 Global Cosmetic Efficacy Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cosmetic Efficacy Testing Revenue by Application (2021-2032)
  3. 6.3 Global Cosmetic Efficacy Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 SGS
  2. 7.1.1 SGS Company Information
  3. 7.1.2 SGS Business Overview
  4. 7.1.3 SGS Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 SGS Cosmetic Efficacy Testing Product Portfolio
  6. 7.1.5 SGS Recent Developments
  7. 7.2 Eurofins
  8. 7.2.1 Eurofins Company Information
  9. 7.2.2 Eurofins Business Overview
  10. 7.2.3 Eurofins Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Eurofins Cosmetic Efficacy Testing Product Portfolio
  12. 7.2.5 Eurofins Recent Developments
  13. 7.3 Measurlabs
  14. 7.3.1 Measurlabs Company Information
  15. 7.3.2 Measurlabs Business Overview
  16. 7.3.3 Measurlabs Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Measurlabs Cosmetic Efficacy Testing Product Portfolio
  18. 7.3.5 Measurlabs Recent Developments
  19. 7.4 QACS labs
  20. 7.4.1 QACS labs Company Information
  21. 7.4.2 QACS labs Business Overview
  22. 7.4.3 QACS labs Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 QACS labs Cosmetic Efficacy Testing Product Portfolio
  24. 7.4.5 QACS labs Recent Developments
  25. 7.5 Chemleg
  26. 7.5.1 Chemleg Company Information
  27. 7.5.2 Chemleg Business Overview
  28. 7.5.3 Chemleg Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Chemleg Cosmetic Efficacy Testing Product Portfolio
  30. 7.5.5 Chemleg Recent Developments
  31. 7.6 Evalulab
  32. 7.6.1 Evalulab Company Information
  33. 7.6.2 Evalulab Business Overview
  34. 7.6.3 Evalulab Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Evalulab Cosmetic Efficacy Testing Product Portfolio
  36. 7.6.5 Evalulab Recent Developments
  37. 7.7 QIMA Life Sciences
  38. 7.7.1 QIMA Life Sciences Company Information
  39. 7.7.2 QIMA Life Sciences Business Overview
  40. 7.7.3 QIMA Life Sciences Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 QIMA Life Sciences Cosmetic Efficacy Testing Product Portfolio
  42. 7.7.5 QIMA Life Sciences Recent Developments
  43. 7.8 Intertek
  44. 7.8.1 Intertek Company Information
  45. 7.8.2 Intertek Business Overview
  46. 7.8.3 Intertek Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Intertek Cosmetic Efficacy Testing Product Portfolio
  48. 7.8.5 Intertek Recent Developments
  49. 7.9 Biorius
  50. 7.9.1 Biorius Company Information
  51. 7.9.2 Biorius Business Overview
  52. 7.9.3 Biorius Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Biorius Cosmetic Efficacy Testing Product Portfolio
  54. 7.9.5 Biorius Recent Developments
  55. 7.10 Oxford Biosciences
  56. 7.10.1 Oxford Biosciences Company Information
  57. 7.10.2 Oxford Biosciences Business Overview
  58. 7.10.3 Oxford Biosciences Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Oxford Biosciences Cosmetic Efficacy Testing Product Portfolio
  60. 7.10.5 Oxford Biosciences Recent Developments
  61. 7.11 FDA
  62. 7.11.1 FDA Company Information
  63. 7.11.2 FDA Business Overview
  64. 7.11.3 FDA Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 FDA Cosmetic Efficacy Testing Product Portfolio
  66. 7.11.5 FDA Recent Developments
  67. 7.12 CTI
  68. 7.12.1 CTI Company Information
  69. 7.12.2 CTI Business Overview
  70. 7.12.3 CTI Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 CTI Cosmetic Efficacy Testing Product Portfolio
  72. 7.12.5 CTI Recent Developments
  73. 7.13 Luamed
  74. 7.13.1 Luamed Company Information
  75. 7.13.2 Luamed Business Overview
  76. 7.13.3 Luamed Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Luamed Cosmetic Efficacy Testing Product Portfolio
  78. 7.13.5 Luamed Recent Developments
  79. 7.14 Cosmeservice
  80. 7.14.1 Cosmeservice Company Information
  81. 7.14.2 Cosmeservice Business Overview
  82. 7.14.3 Cosmeservice Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cosmeservice Cosmetic Efficacy Testing Product Portfolio
  84. 7.14.5 Cosmeservice Recent Developments
  85. 7.15 CPT Labs
  86. 7.15.1 CPT Labs Company Information
  87. 7.15.2 CPT Labs Business Overview
  88. 7.15.3 CPT Labs Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 CPT Labs Cosmetic Efficacy Testing Product Portfolio
  90. 7.15.5 CPT Labs Recent Developments
  91. 7.16 Microchem Laboratory
  92. 7.16.1 Microchem Laboratory Company Information
  93. 7.16.2 Microchem Laboratory Business Overview
  94. 7.16.3 Microchem Laboratory Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Microchem Laboratory Cosmetic Efficacy Testing Product Portfolio
  96. 7.16.5 Microchem Laboratory Recent Developments
  97. 7.17 XCellR9
  98. 7.17.1 XCellR9 Company Information
  99. 7.17.2 XCellR9 Business Overview
  100. 7.17.3 XCellR9 Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 XCellR9 Cosmetic Efficacy Testing Product Portfolio
  102. 7.17.5 XCellR9 Recent Developments
  103. 7.18 Future Cosmetics
  104. 7.18.1 Future Cosmetics Company Information
  105. 7.18.2 Future Cosmetics Business Overview
  106. 7.18.3 Future Cosmetics Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Future Cosmetics Cosmetic Efficacy Testing Product Portfolio
  108. 7.18.5 Future Cosmetics Recent Developments
  109. 7.19 Complife Group
  110. 7.19.1 Complife Group Company Information
  111. 7.19.2 Complife Group Business Overview
  112. 7.19.3 Complife Group Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Complife Group Cosmetic Efficacy Testing Product Portfolio
  114. 7.19.5 Complife Group Recent Developments
  115. 7.20 Melbec Microbiology
  116. 7.20.1 Melbec Microbiology Company Information
  117. 7.20.2 Melbec Microbiology Business Overview
  118. 7.20.3 Melbec Microbiology Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Melbec Microbiology Cosmetic Efficacy Testing Product Portfolio
  120. 7.20.5 Melbec Microbiology Recent Developments
  121. 7.21 Kirei Testing
  122. 7.21.1 Kirei Testing Company Information
  123. 7.21.2 Kirei Testing Business Overview
  124. 7.21.3 Kirei Testing Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Kirei Testing Cosmetic Efficacy Testing Product Portfolio
  126. 7.21.5 Kirei Testing Recent Developments
  127. 7.22 Accugen Labs
  128. 7.22.1 Accugen Labs Company Information
  129. 7.22.2 Accugen Labs Business Overview
  130. 7.22.3 Accugen Labs Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Accugen Labs Cosmetic Efficacy Testing Product Portfolio
  132. 7.22.5 Accugen Labs Recent Developments
  133. 7.23 MSL Solution
  134. 7.23.1 MSL Solution Company Information
  135. 7.23.2 MSL Solution Business Overview
  136. 7.23.3 MSL Solution Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  137. 7.23.4 MSL Solution Cosmetic Efficacy Testing Product Portfolio
  138. 7.23.5 MSL Solution Recent Developments
  139. 7.24 BluTest
  140. 7.24.1 BluTest Company Information
  141. 7.24.2 BluTest Business Overview
  142. 7.24.3 BluTest Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  143. 7.24.4 BluTest Cosmetic Efficacy Testing Product Portfolio
  144. 7.24.5 BluTest Recent Developments
  145. 7.25 Creative Bioarray
  146. 7.25.1 Creative Bioarray Company Information
  147. 7.25.2 Creative Bioarray Business Overview
  148. 7.25.3 Creative Bioarray Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Creative Bioarray Cosmetic Efficacy Testing Product Portfolio
  150. 7.25.5 Creative Bioarray Recent Developments
  151. 7.26 Iwase Cosfa
  152. 7.26.1 Iwase Cosfa Company Information
  153. 7.26.2 Iwase Cosfa Business Overview
  154. 7.26.3 Iwase Cosfa Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Iwase Cosfa Cosmetic Efficacy Testing Product Portfolio
  156. 7.26.5 Iwase Cosfa Recent Developments
  157. 7.27 Dermaclaim Lab
  158. 7.27.1 Dermaclaim Lab Company Information
  159. 7.27.2 Dermaclaim Lab Business Overview
  160. 7.27.3 Dermaclaim Lab Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Dermaclaim Lab Cosmetic Efficacy Testing Product Portfolio
  162. 7.27.5 Dermaclaim Lab Recent Developments
  163. 7.28 Labskin
  164. 7.28.1 Labskin Company Information
  165. 7.28.2 Labskin Business Overview
  166. 7.28.3 Labskin Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Labskin Cosmetic Efficacy Testing Product Portfolio
  168. 7.28.5 Labskin Recent Developments
  169. 7.29 PCR
  170. 7.29.1 PCR Company Information
  171. 7.29.2 PCR Business Overview
  172. 7.29.3 PCR Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  173. 7.29.4 PCR Cosmetic Efficacy Testing Product Portfolio
  174. 7.29.5 PCR Recent Developments
  175. 7.30 TIBD
  176. 7.30.1 TIBD Company Information
  177. 7.30.2 TIBD Business Overview
  178. 7.30.3 TIBD Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  179. 7.30.4 TIBD Cosmetic Efficacy Testing Product Portfolio
  180. 7.30.5 TIBD Recent Developments
  181. 7.31 Alliance Analytical Laboratories
  182. 7.31.1 Alliance Analytical Laboratories Company Information
  183. 7.31.2 Alliance Analytical Laboratories Business Overview
  184. 7.31.3 Alliance Analytical Laboratories Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  185. 7.31.4 Alliance Analytical Laboratories Cosmetic Efficacy Testing Product Portfolio
  186. 7.31.5 Alliance Analytical Laboratories Recent Developments
  187. 7.32 Abich
  188. 7.32.1 Abich Company Information
  189. 7.32.2 Abich Business Overview
  190. 7.32.3 Abich Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  191. 7.32.4 Abich Cosmetic Efficacy Testing Product Portfolio
  192. 7.32.5 Abich Recent Developments
  193. 7.33 HAPPI
  194. 7.33.1 HAPPI Company Information
  195. 7.33.2 HAPPI Business Overview
  196. 7.33.3 HAPPI Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  197. 7.33.4 HAPPI Cosmetic Efficacy Testing Product Portfolio
  198. 7.33.5 HAPPI Recent Developments
  199. 7.34 Cosmetri
  200. 7.34.1 Cosmetri Company Information
  201. 7.34.2 Cosmetri Business Overview
  202. 7.34.3 Cosmetri Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  203. 7.34.4 Cosmetri Cosmetic Efficacy Testing Product Portfolio
  204. 7.34.5 Cosmetri Recent Developments
  205. 7.35 MCS
  206. 7.35.1 MCS Company Information
  207. 7.35.2 MCS Business Overview
  208. 7.35.3 MCS Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  209. 7.35.4 MCS Cosmetic Efficacy Testing Product Portfolio
  210. 7.35.5 MCS Recent Developments
  211. 7.36 Spincontrol
  212. 7.36.1 Spincontrol Company Information
  213. 7.36.2 Spincontrol Business Overview
  214. 7.36.3 Spincontrol Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  215. 7.36.4 Spincontrol Cosmetic Efficacy Testing Product Portfolio
  216. 7.36.5 Spincontrol Recent Developments
8 North America
  1. 8.1 North America Cosmetic Efficacy Testing Revenue (2021-2032)
  2. 8.2 North America Cosmetic Efficacy Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Cosmetic Efficacy Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Cosmetic Efficacy Testing Revenue by Type (2027-2032)
  5. 8.3 North America Cosmetic Efficacy Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Cosmetic Efficacy Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Cosmetic Efficacy Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Cosmetic Efficacy Testing Revenue by Application (2027-2032)
  9. 8.5 North America Cosmetic Efficacy Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Cosmetic Efficacy Testing Revenue by Country
  11. 8.6.1 North America Cosmetic Efficacy Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cosmetic Efficacy Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Cosmetic Efficacy Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cosmetic Efficacy Testing Revenue (2021-2032)
  2. 9.2 Europe Cosmetic Efficacy Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cosmetic Efficacy Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cosmetic Efficacy Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Cosmetic Efficacy Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cosmetic Efficacy Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cosmetic Efficacy Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cosmetic Efficacy Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Cosmetic Efficacy Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cosmetic Efficacy Testing Revenue by Country
  11. 9.6.1 Europe Cosmetic Efficacy Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cosmetic Efficacy Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cosmetic Efficacy Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cosmetic Efficacy Testing Revenue (2021-2032)
  2. 10.2 China Cosmetic Efficacy Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Cosmetic Efficacy Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Cosmetic Efficacy Testing Revenue by Type (2027-2032)
  5. 10.3 China Cosmetic Efficacy Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Cosmetic Efficacy Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Cosmetic Efficacy Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Cosmetic Efficacy Testing Revenue by Application (2027-2032)
  9. 10.5 China Cosmetic Efficacy Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cosmetic Efficacy Testing Revenue (2021-2032)
  2. 11.2 Asia Cosmetic Efficacy Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cosmetic Efficacy Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cosmetic Efficacy Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Cosmetic Efficacy Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cosmetic Efficacy Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cosmetic Efficacy Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cosmetic Efficacy Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Cosmetic Efficacy Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cosmetic Efficacy Testing Revenue by Country
  11. 11.6.1 Asia Cosmetic Efficacy Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cosmetic Efficacy Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cosmetic Efficacy Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cosmetic Efficacy Testing Revenue (2021-2032)
  2. 12.2 SAMEA Cosmetic Efficacy Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cosmetic Efficacy Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cosmetic Efficacy Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cosmetic Efficacy Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cosmetic Efficacy Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cosmetic Efficacy Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cosmetic Efficacy Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cosmetic Efficacy Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cosmetic Efficacy Testing Revenue by Country
  11. 12.6.1 SAMEA Cosmetic Efficacy Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cosmetic Efficacy Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cosmetic Efficacy Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research